Symbol
CANF on NYSE
Investment type
Equity / Ordinary Shares, no par value
Latest Disclosed Shares Owned
157,382,700 shares
Security Ownership %
4.1%

Orca Capital AG ownership in Can-Fite BioPharma Ltd. Ordinary Shares, no par value (CANF)

23 Apr 2025 - Orca Capital AG has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 157,382,700 shares of Can-Fite BioPharma Ltd. Ordinary Shares, no par value (CANF). This represents 4.1% ownership of the company. In their previous filing dated 16 Apr 2025, Orca Capital AG had reported owning 375,000,000 shares, indicating a decrease of +58%. .